These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 17295818)

  • 21. [Surgical therapy for esophageal carcinoma: a prospective 20-year analysis].
    Gockel I; Sultanov FS; Domeyer M; Trinh TT; Gönner U; Junginger T
    Zentralbl Chir; 2008 Jun; 133(3):260-6. PubMed ID: 18563693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma.
    Rizk NP; Bach PB; Schrag D; Bains MS; Turnbull AD; Karpeh M; Brennan MF; Rusch VW
    J Am Coll Surg; 2004 Jan; 198(1):42-50. PubMed ID: 14698310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transhiatal versus transthoracic esophagectomy for clinical stage I esophageal carcinoma.
    Berdejo L
    Hepatogastroenterology; 1995; 42(6):789-91. PubMed ID: 8847024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor length as a prognostic factor in esophageal malignancy: univariate and multivariate survival analyses.
    Griffiths EA; Brummell Z; Gorthi G; Pritchard SA; Welch IM
    J Surg Oncol; 2006 Mar; 93(4):258-67. PubMed ID: 16496364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left thoracotomy approach for resection of carcinoma of the oesophagus and cardia.
    Sabanathan S; Eng J
    Ann Ital Chir; 1992; 63(1):25-31. PubMed ID: 1605442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local recurrence after total or subtotal esophagectomy for esophageal cancer.
    Blewett CJ; Miller JD; Ramlawi B; Young JE; BennettWF ; Urschel JD
    J Exp Clin Cancer Res; 2001 Mar; 20(1):17-9. PubMed ID: 11370823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ivor Lewis esophagectomy with two-field lymph node dissection for squamous cell carcinoma of the lower thoracic esophagus].
    Wu J; Chai Y; Zhou XM; Chen QX; Yan FL
    Ai Zheng; 2007 Mar; 26(3):307-11. PubMed ID: 17355797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome following surgery for squamous cell carcinoma of the oesophagus.
    Yong EL; Han XP; Watson DI; Devitt PG; Jamieson GG; Thompson SK
    ANZ J Surg; 2009 Oct; 79(10):724-8. PubMed ID: 19878168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of surgical volume on hospital mortality and 5-year survival for carcinoma of the oesophagus and gastric cardia.
    Wenner J; Zilling T; Bladström A; Alvegård TA
    Anticancer Res; 2005; 25(1B):419-24. PubMed ID: 15816605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Esophagectomy for carcinoma: impact of age on clinical results and survival].
    Bonavina L; Incarbone R; Saino G; Peracchia A
    Chir Ital; 2002; 54(5):587-90. PubMed ID: 12469453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unplanned splenectomy during oesophagectomy does not affect survival.
    Black E; Niamat J; Boddu S; Martin-Ucar A; Duffy JP; Morgan WE; Beggs FD
    Eur J Cardiothorac Surg; 2006 Feb; 29(2):244-7. PubMed ID: 16388954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anastomotic leakage after esophagectomy for cancer: a mortality-free experience.
    Sarela AI; Tolan DJ; Harris K; Dexter SP; Sue-Ling HM
    J Am Coll Surg; 2008 Mar; 206(3):516-23. PubMed ID: 18308224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of staging investigations for oesophago-gastric carcinoma.
    Clements DM; Bowrey DJ; Havard TJ
    Eur J Surg Oncol; 2004 Apr; 30(3):309-12. PubMed ID: 15028314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New insights in the lymphatic spread of oesophageal cancer and its implications for the extent of surgical resection.
    Cense HA; van Eijck CH; Tilanus HW
    Best Pract Res Clin Gastroenterol; 2006; 20(5):893-906. PubMed ID: 16997168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival effect of neoadjuvant radiotherapy before esophagectomy for patients with esophageal cancer: a surveillance, epidemiology, and end-results study.
    Schwer AL; Ballonoff A; McCammon R; Rusthoven K; D'Agostino RB; Schefter TE
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):449-55. PubMed ID: 18538500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Esophageal cancer subtypes and survival rates at the VA Caribbean Healthcare System: a 10-year experience.
    González Ortiz DI; Toro DH
    Bol Asoc Med P R; 2009; 101(3):14-7. PubMed ID: 20120980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma?
    Chen G; Wang Z; Liu XY; Liu FY
    Ann Thorac Surg; 2009 Jun; 87(6):1697-702. PubMed ID: 19463580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carcinoma of the hypopharynx and the cervical oesophagus: a surgical challenge.
    Böttger T; Bumb P; Dutkowski P; Schlick T; Junginger T
    Eur J Surg; 1999 Oct; 165(10):940-6. PubMed ID: 10574101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The local control of radiotherapy following Ivor-Lewis esophagectomy in the patients with stage II A middle-third thoracic esophageal cancer].
    Zhang MY; Wang Z; Liu XY; Chen G; Liu FY
    Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(14):1048-50. PubMed ID: 19094527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimally invasive esophagectomy for stage I and II esophageal cancer.
    Yamamoto S; Kawahara K; Maekawa T; Shiraishi T; Shirakusa T
    Ann Thorac Surg; 2005 Dec; 80(6):2070-5. PubMed ID: 16305846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.